## Clinical Assessment: Septic Shock Requiring Vasopressor Therapy This patient meets **septic shock** criteria (Sepsis-3 definition): - **Infection source:** Community-acquired pneumonia - **Hypotension:** BP 88/54 mmHg (MAP ~65 mmHg or below) - **Elevated lactate:** 4.1 mmol/L (>2 mmol/L) - **Organ dysfunction:** Altered mental status (GCS 13) - **Already on antibiotics for 18 hours** — infection is being treated ## Why Noradrenaline Is the Correct Next Step **Key Point:** Per the **Surviving Sepsis Campaign 2021 guidelines**, vasopressors (noradrenaline) should be initiated **early** in septic shock to achieve MAP ≥65 mmHg. The critical question is whether this patient still needs more fluid or needs vasopressors. ### Interpreting the Hemodynamic Parameters | Parameter | Patient Value | Interpretation | |-----------|--------------|----------------| | CVP | 8 cmH₂O | Within acceptable range (8–12 cmH₂O in mechanically ventilated patients); **not indicative of severe hypovolemia** | | ScvO₂ | 62% | Low (target >70%), but this reflects distributive physiology of sepsis, not necessarily pure hypovolemia | | Lactate | 4.1 mmol/L | Elevated — tissue hypoperfusion present | | BP | 88/54 mmHg | Persistent hypotension despite 18 hours of antibiotics | A CVP of 8 cmH₂O indicates **adequate preload** — this patient is not in a profoundly hypovolemic state. The Surviving Sepsis Campaign 2021 explicitly states that vasopressors should **not** be withheld pending further fluid loading when MAP is critically low and preload is adequate. ### The Danger of Delaying Vasopressors **Clinical Pearl:** Administering additional fluid boluses to a patient with adequate CVP (8 cmH₂O) and persistent hypotension risks: 1. **Fluid overload** — worsening pulmonary edema in a patient with pneumonia 2. **Dilutional coagulopathy** 3. **Delayed organ perfusion** — every minute of MAP <65 mmHg increases risk of AKI, hepatic dysfunction, and mortality The **CLASSIC trial (2022)** and **CLOVERS trial (2023)** both support a **restrictive fluid strategy** in septic shock, favoring early vasopressor use over liberal fluid resuscitation. ## Why Other Options Are Incorrect - **Option A (Broaden antibiotics):** Ceftriaxone + azithromycin is guideline-concordant empiric therapy for CAP. Pseudomonas coverage is NOT indicated without risk factors (structural lung disease, prior antibiotics, immunosuppression, healthcare-associated exposure). Premature broadening increases resistance and toxicity. - **Option B (Echocardiography):** While echo may be useful later to assess cardiac function, it is NOT the immediate priority when MAP is critically low. Stabilize hemodynamics first. - **Option D (500 mL fluid bolus):** CVP of 8 cmH₂O indicates adequate preload. Further fluid loading in a patient with pneumonia risks worsening respiratory failure. The Surviving Sepsis Campaign 2021 recommends against routine fluid boluses when preload is adequate; vasopressors are the appropriate next step. ## Resuscitation Endpoints | Parameter | Target | Patient Status | |-----------|--------|---------------| | MAP | ≥65 mmHg | **Not met** → vasopressor needed | | Lactate | <2 mmol/L or >10% clearance/6 hrs | Elevated at 4.1 | | ScvO₂ | >70% | Low at 62% | | CVP | 8–12 cmH₂O | **Met** at 8 cmH₂O | **High-Yield:** Per Surviving Sepsis Campaign 2021 (Rhodes et al., *Intensive Care Med* 2017; updated 2021): **Noradrenaline is the first-line vasopressor** in septic shock, targeting MAP ≥65 mmHg. It should be initiated promptly when hypotension persists and preload is adequate, rather than continuing fluid resuscitation beyond the initial 30 mL/kg. > *Reference: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Evans L et al. Intensive Care Med. 2021;47(11):1181–1247.*
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.